Hello, this is Hontan!Today, I would like to write about the theme that 'consistency is key in math.'I previously wrote about ...

Small breed dogs carry a disproportionate burden of heart disease. Cavalier King Charles Spaniels, Dachshunds, Chihuahuas, Pomeranians, and Shih Tzus develop myxomatous mitral valve disease, the most ...

Ever since I started my part-time job at a cram school, my brain has been forced to work at full capacity like never ...

This rugged yet refined backpack aims to keep all of your kit in order, with separate spaces for everything from your largest ...

VANCOUVER, British Columbia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Zacatecas Silver Corp. (TSXV: ZAC | OTCQB: ZCTSF | FRA: 7TV) ( ...

Five-year Olympus follow-up data published in Therapeutic Advances in Urology reinforce the long-term durability of response with JELMYTOResults ...

The data showcased are from three Phase 1b clinical studies of IBI363/TAK-928 in first-line NSCLC, first-line G/GEJA, and immunotherapy-resistant lung adenocarcinoma, further supporting its potential ...

Claude Fable 5.1 scores 43 to Mistral Large 4's 26 on Artificial Analysis v5 and costs 12x more per output token. The licence decides more than the gap.

In the Phase 3 MagnetisMM-32 trial, ELREXFIO demonstrated a clinically meaningful and statistically significant benefit for patients whose disease progressed after anti-CD38 therapy and lenalidomide, ...

ISASOCUT: Subcutaneous Isatuximab With On-Body Injector in Newly Diagnosed Multiple Myeloma / cancer, Headlines, Hematology, ...

Zacatecas Silver is pleased to report results from a reconnaissance rock chip sampling program at its Cumaro gold-silver project. Assays returned up to 40.6 g/t gold and 253 g/t silver from ...

Pfizer Inc. announced topline results from the Phase 3 MagnetisMM-32 study evaluating ELREXFIO (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) who received ...